Elekta announced it is collaborating with IBM Watson Health to offer Watson for Oncology with Elekta’s cancer care solutions. Under the terms of a new agreement, Elekta will sell Watson for Oncology beginning in early 2018 as a clinical decision support (CDS) solution paired within Elekta’s digital cancer care solutions, including the Mosaiq oncology information system (OIS). Elekta intends to offer both solutions in most markets around the world including the U.S., Brazil, certain major European and Asian markets, as well as India and Australia.

Considerations for VNA Implementation

The majority of U.S.-based healthcare facilities are either considering or implementing the consolidation of their medical image archiving in the form of a vendor neutral archive (VNA). Early experiences have taught that it is not trivial to select the right VNA, and have revealed several pitfalls during the implementation phase.

Amazon, Berkshire Hathaway and JPMorgan Chase & Co. announced that they are partnering on ways to address healthcare for their U.S. employees, with the aim of improving employee satisfaction and reducing costs. The three companies, which bring their scale and complementary expertise to this long-term effort, will pursue this objective through an independent company that is free from profit-making incentives and constraints, according to the companies. The initial focus of the new company will be on technology solutions that will provide U.S. employees and their families with simplified, high-quality and transparent healthcare at a reasonable cost.

Investigations are underway at a hospital in Mumbai, India, after a man was killed when he was sucked into a magnetic resonance imaging (MRI) machine while carrying a metallic oxygen cylinder into the exam room. Two hospital staff members have been arrested for causing death due to negligence, according to the French news agency Agence France-Presse (AFP).

Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for two sites in London: Charing Cross Hospital and Hammersmith Hospital. RayStation was selected following a thorough evaluation of all potential treatment planning systems on the market.

Bracco Diagnostics Inc. announced the labeling of its contrast agent MultiHance has obtained U.S. Food and Drug Administration (FDA) approval for an extension to include magnetic resonance imaging (MRI) of the central nervous system (CNS) in pediatric patients younger than 2 years of age (including term neonates). The agent may now be used in this patient population to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine and associated tissues.

Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients do not receive these treatments and in turn have lower overall survival, according to research from The University of Texas MD Anderson Cancer Center.

Primary care providers and hospital doctors around the world can now access the imaging referral guidelines from the U.K.’s Royal College of Radiologists, newly integrated into the OrderWise clinical decision support (CDS) solution created by Canadian CDS company MedCurrent.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now